The a2 Milk Company Limited (OTC:ACOPY) Shareholder/Analyst Call November 19, 2025 5:00 PM EST Company Participants Philippa Greenwood David Bortolussi - MD, CEO & Director Chante Mueller - Head of Investor Relations Kathryn Mitchell Pei-Yu Yu Lain Jager Grant Dempsey Andrew Clarke Presentation Philippa Greenwood Good morning, everyone, and welcome to The a2 Milk Company's 2025 Annual General Meeting. My name is Pip Greenwood, and I'm honored to serve as the Chair of the Board.
| Food Products Industry | Consumer Staples Sector | David L. Bortolussi CEO | OTC PINK Exchange | 002201101 CUSIP |
| NZ Country | 511 Employees | 9 Jul 2026 Last Dividend | - Last Split | - IPO Date |
The a2 Milk Company Limited, originally recognized as A2 Corporation Limited until its name change in April 2014, is a distinguished enterprise entrenched in Auckland, New Zealand, since its inception in 2000. This company has carved its niche by specializing in the sale of A2 protein type branded milk and related products. It has broadened its market reach beyond its local territories of Australia and New Zealand to include China, the rest of Asia, and the United States. The company distinguishes itself through its dedication to providing premium milk products that contain only the A2 type of beta-casein protein, aiming to offer a distinct and potentially more digestible alternative to the common A1 protein found in regular cow’s milk. Its operations are not limited to the sale of milk; the company is also involved in the manufacturing and selling of nutritional and commodity products, illustrating a versatile business model aimed at catering to a diverse range of consumer needs and preferences in the dairy sector.
This flagship product line includes milk that contains only the A2 type of beta-casein protein. Targeted at consumers looking for a milk option that may be easier to digest compared to regular milk, which contains both A1 and A2 proteins. The a2 Milk range is designed to provide all the natural benefits of cows' milk without the digestive discomfort some experience from the A1 protein.
Under the a2 Platinum brand, the company offers premium infant formula and nutritional products targeting different life stages. This range includes infant formula, follow-on formula, and toddler milk drink. These products are formulated to support the nutritional needs of infants and young children, providing a high-quality alternative for parents and caregivers seeking options that avoid the A1 protein.
In addition to its core offerings of A2 protein-type branded milk and infant nutrition products, The a2 Milk Company Limited also ventures into the manufacturing and sale of a wider range of nutritional and commodity products. These include nutritional supplements and other dairy derivatives aimed at further fulfilling the health and dietary needs of their diverse consumer base.